Pharmacogenomics in diverse practice settings: Implementation beyond major metropolitan areas

Elizabeth H. Dorfman, Susan Brown Trinidad, Chelsea T. Morales, Kevin Howlett, Wylie Burke, Erica L. Woodahl

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


Aim: The limited formal study of the clinical feasibility of implementing pharmacogenomic tests has thus far focused on providers at large medical centers in urban areas. Our research focuses on small metropolitan, rural and tribal practice settings. Materials & methods: We interviewed 17 healthcare providers in western Montana regarding pharmacogenomic testing. Results: Participants were optimistic about the potential of pharmacogenomic tests, but noted unique barriers in small and rural settings including cost, adherence, patient acceptability and testing timeframe. Participants in tribal settings identified heightened sensitivity to genetics and need for community leadership approval as additional considerations. Conclusion: Implementation differences in small metropolitan, rural and tribal communities may affect pharmacogenomic test adoption and utilization, potentially impacting many patients.

Original languageEnglish
Pages (from-to)227-237
Number of pages11
Issue number3
StatePublished - Mar 1 2015


  • Alaska Native
  • American Indian
  • implementation
  • indigenous populations
  • pharmacogenetics
  • pharmacogenomics
  • rural


Dive into the research topics of 'Pharmacogenomics in diverse practice settings: Implementation beyond major metropolitan areas'. Together they form a unique fingerprint.

Cite this